| ABT | abatacept |
| ADA | adalimumab |
| BUC | bucillamine |
| CDAI | clinical disease activity index |
| CRP | C-reactive protein |
| CZP | certolizumab pegol |
| DAS | disease activity score |
| ETN | etanercept |
| GLM | golimumab |
| HAQ | health assessment questionnaire |
| IFX | infliximab |
| IGU | iguratimod |
| IgG | Immunoglobulin G |
| KL-6 | krebs von den Lungen-6 |
| LDH | lactate dehydrogenase |
| LTBI | latent tuberculosis infection |
| MPDN | methylprednisolone |
| MTX | methotrexate |
| NTM | nontuberculous mycobacteriosis |
| PCP | Pneumocystis Pneumonia |
| PDN | prednisolone |
| RA | rheumatoid arthritis |
| SASP | salazosulfapyridine |
| SDAI | simplified disease activity Index |
| TAC | tacrolimus |
| TCZ | tocilizumab |
| TMP/SMX | trimethoprim/sulfamethoxazole |
| TOF | tofacitinib |
| WBC | white blood cells |
| bDMARDs | biological disease modified anti-rheumatic drugs |
| tsDMARDs | targeted synthetic disease modified anti-rheumatic drugs |